http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103751133-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fd55fb76f017d561cbfcb0b7fec0c94 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
filingDate | 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481986bec347810ee8c7e6bd42ad480a |
publicationDate | 2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103751133-A |
titleOfInvention | Dipyridamole oral-disintegrating tablet |
abstract | The invention provides a dipyridamole oral-disintegrating tablet. The dipyridamole oral-disintegrating tablet is characterized in that the dipyridamole oral-disintegrating tablet contains a physiologically effective amount of dipyridamole and a necessary pharmaceutically-acceptable excipient. The dipyridamole oral-disintegrating tablet comprises 5-10wt% of dipyridamole. The necessary pharmaceutically-acceptable excipient is a mixture of a filler, an odor mask agent, a disintegrating agent, a surfactant, a binder, a lubricant and a flow promoter. The dipyridamole oral-disintegrating tablet has the advantages of fast disintegrating rate, excellent taste, stable quality and reliable curative effects and can improve patient compliance to a drug. |
priorityDate | 2011-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.